Inhibitory monoclonal antibody targeting ADAM17 expressed on cancer cells.
Saha N, Xu K, Zhu Z, Robev D, Kalidindi T, Xu Y, Himanen J, de Stanchina E, Pillarsetty NVK, Dimitrov DS, Nikolov DB.
Saha N, et al. Among authors: xu k, xu y.
Transl Oncol. 2022 Jan;15(1):101265. doi: 10.1016/j.tranon.2021.101265. Epub 2021 Nov 9.
Transl Oncol. 2022.
PMID: 34768098
Free PMC article.